首页> 美国卫生研究院文献>Tomography >A Systematic Pipeline for the Objective Comparison of Whole-Brain Spectroscopic MRI with Histology in Biopsy Specimens from Grade 3 Glioma
【2h】

A Systematic Pipeline for the Objective Comparison of Whole-Brain Spectroscopic MRI with Histology in Biopsy Specimens from Grade 3 Glioma

机译:一种用于比较3级脑胶质瘤活检标本中全脑光谱MRI和组织学的客观比较的系统管线

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The diagnosis, prognosis, and management of patients with gliomas are largely dictated by the pathological analysis of tissue biopsied from a selected region within the lesion. However, the heterogeneous and infiltrative nature of gliomas make it difficult to identify the optimal region for biopsy with conventional magnetic resonance imaging (MRI). This is particularly true for low-grade gliomas, which are often nonenhancing tumors. To improve the management of patients with such tumors, neuro-oncology requires an imaging modality that can specifically identify a tumor's most anaplastic/aggressive region(s) for biopsy targeting. The addition of metabolic mapping using spectroscopic MRI (sMRI) to supplement conventional MRI could improve biopsy targeting and, ultimately, diagnostic accuracy. Here, we describe a pipeline for the integration of state-of-the-art, high-resolution, whole-brain 3-dimensional sMRI maps into a stereotactic neuronavigation system for guiding biopsies in gliomas with nonenhancing components. We also outline a machine-learning method for automated histological analysis that generates normalized, quantitative metrics describing tumor infiltration in immunohistochemically stained tissue specimens. As a proof of concept, we describe the combination of these 2 techniques in a small cohort of patients with grade 3 glioma. With this work, we aim to present a systematic pipeline to stimulate histopathological image validation of advanced MRI techniques, such as sMRI.
机译:脑胶质瘤患者的诊断,预后和管理很大程度上取决于从病变内选定区域进行活检组织的病理分析。然而,神经胶质瘤的异质性和浸润性使得难以通过常规磁共振成像(MRI)来确定活检的最佳区域。对于经常是非增强型肿瘤的低度神经胶质瘤尤其如此。为了改善对此类肿瘤患者的管理,神经肿瘤学需要一种成像方式,可以专门识别肿瘤的最变性/侵袭性区域以进行活检。使用光谱MRI(sMRI)补充代谢图谱以补充常规MRI可以改善活检目标,并最终提高诊断准确性。在这里,我们描述了将最新技术,高分辨率,全脑3维sMRI映射集成到立体定向神经导航系统中的流程,该系统可指导神经胶质瘤中不增强成分的活检。我们还概述了一种用于自动组织学分析的机器学习方法,该方法可生成描述免疫组织化学染色的组织标本中肿瘤浸润的标准化定量指标。作为概念的证明,我们将这两种技术的组合用于一小群3级脑胶质瘤患者。通过这项工作,我们旨在提出一个系统化的流程,以刺激高级MRI技术(例如sMRI)的组织病理学图像验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号